Fig. 3From: Effect of entecavir and tenofovir disoproxil fumarate on hepatocellular carcinoma in subjects with chronic hepatitis B: a meta-analysisDifference between the impact of entecavir and tenofovir disoproxil concerning HCC occurrence in chronic HBV subjectsBack to article page